Mahta Mortezavi, MD

Pfizer

Disclosure(s): Pfizer: employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-108) Ibuzatrelvir Potently Reduced Viral RNA Levels Despite the High Rate of Anti-S Seropositivity: a Post Hoc Analysis of Serology in the Phase 2b Study in Adults Without Risk Factors for Severe COVID-19
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET